Markets And Molecules: A Pharmaceutical Primer From The South
Name
Medical Anthropology proofs.pdf
Description
Markets And Molecules: A Pharmaceutical Primer From The South
Size
12.44 MB
Format
Adobe PDF
Checksum (MD5)
90c7fe62ab0791c4903e151d50953655
Author(s)
Banerjee, Dwaipayan
Date Issued
July 2016
Journal
Medical Anthropology
Publisher
Taylor & Francis
Citation
Banerjee, Dwaipayan. “Markets And Molecules: A Pharmaceutical Primer From The South.” Medical Anthropology (July 13, 2016).
Version
Author's final manuscript
Abstract
The Indian pharmaceutical industry has historically manufactured low-cost drugs for the global poor. Activist mobilizations at the height of the HIV/AIDS epidemic revealed a vast cost gap between global brands and Indian generics, much to the embarrassment of Euro-American corporations that were in the habit of pricing drugs for only the wealthy or well insured. As new drug access controversies focus on anticancer therapies, they reveal new flows of international capital, emergent genetic technologies, and increasingly coercive trade regimes. Together these favor multi-national corporate oligopolies, which imperil the legacy of HIV/AIDS activism and the future availability of essential life-saving drugs for the work of global public health. In this essay, I describe how the future of the right to drug access rests uneasily, and potentially calamitously, on a shifting balance of power between global south interests and Euro-American pharmaceutical capital.
MIT Department
Program in Media Arts and Sciences (Massachusetts Institute of Technology)
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1080/01459740.2016.1209499
